DOCSLIB.ORG

Susceptibility and Resistance Data

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Susceptibility and Resistance Data toku-e logo For a complete list of references, please visit antibiotics.toku-e.com Cefpodoxime Proxetil Microorganism Genus, Species, and Strain (if shown) Concentration Range (μg/ml)Susceptibility and Bacteroides bivius 0.25 Minimum－ >64 Inhibitory Bacteroides disiens 0.25 － >64 Bacteroides distasonis Concentration0.25 － >64 (MIC) Data Bacteroides fragilis 0.25 － >64 Issue date 01/06/2020 Bacteroides fragilis 8 － 128 Bacteroides fragilis (NCTC 9343) 32 － ? Bacteroides ovatus 0.25 － >64 Bacteroides thetaiotaomicron 0.25 － >64 Bacteroides vulgatus 0.25 － >64 Brucella abortus 0.25 － ? Brucella melitensis 0.25 － ? Brucella suis 0.25 － ? Burkholderia cepacia 16 － >128 Citrobacter amalonaticus 16 － ? Citrobacter amalonaticus (4026 + β­lactamase positive) 8 － ? Citrobacter braakii >16 － ? Citrobacter farmeri 1 － >16 Citrobacter freundii 0.5 － >128 Citrobacter freundii 4 － >16 Citrobacter freundii (3757 + β­lactamase positive) 128 － ? Citrobacter spp. 16 － >16 Citrobacter werkmanii >16 － ? Clostridium difficile 64 － >64 Clostridium histolyticum 0.25 － 16 Clostridium sordellii 0.25 － 16 Clostridium sporogenes 0.25 － 16 Enterobacter aerogenes 0.25 － >64 Enterobacter aerogenes 1 － >16 Enterobacter aerogenes (3701 + β­lactamase positive) 32 － ? Enterobacter amnigenus >16 － ? Enterobacter asburiae >16 － ? Enterobacter cloacae 0.03 － >64 Enterobacter cloacae 0.125 － >128 Enterobacter cloacae 8 － >16 Enterobacter cloacae (22491) 2 － ? Enterobacter cloacae (3146 + β­lactamase positive) 64 － ? Enterobacter cloacae (53 + β­lactamase positive) 32 － ? Enterobacter hormaechei 8 － >16 Enterobacter intermedius >16 － ? Enterobacter sakazakii 0.13 － 1 Enterobacter taylorae >16 － ? Enterobacteriaceae 0.06 － 128 Enterococci 1 － 128 Enterococcus faecalis 1 － >128 Enterococcus faecalis >64 － ? Enterococcus faecalis (ATCC 29212) >32 － ? Enterococcus faecium >64 － ? Enterococcus faecium 128 － >128 Enterococcus liquefaciens >64 － ? Escherichia coli 0.125 － 8 Escherichia coli 0.12 － 512 Escherichia coli ? － ? Escherichia coli (ampicillin-resistant + ceftazidime-resistant) 16 － 32 Escherichia coli (ampicillin-resistant + ceftazidime-susceptible) 0.13 － 0.25 Escherichia coli (ampicillin-susceptible) 0.13 － 0.5 Escherichia coli (ATCC 25922) 0.25 － ? Escherichia coli (ATCC 25922) 0.5 － ? Escherichia coli (ATCC 35218) 0.5 － ? Escherichia coli (NCTC 10418) 0.25 － ? Escherichia coli (OC4075) 1 － ? Escherichia coli (OC4087) >128 － ? Escherichia coli (OC4136) >128 － ? Escherichia coli (OC4138) 32 － ? Escherichia coli (OC4227) 8 － ? Escherichia coli (OC4229) 16 － ? Escherichia coli (OC4249) 64 － ? Escherichia coli (OC6028) 64 － ? Microorganism Genus, Species, and Strain (if shown) Concentration Range (μg/ml)Susceptibility and Escherichia coli (OC6042) 128 Minimum－ ? Inhibitory Escherichia coli (OC6043) >128 － ? Escherichia coli (OC6044) >128 － ? Haemolytic streptococci 0.015 － 0.12 Haemophilus influenzae ≤0.03 － 1 Haemophilus influenzae 0.032 － 0.5 Haemophilus influenzae (ampicillin-resistant) 0.03 － 1 Haemophilus influenzae (ampicillin-susceptible) 0.03 － 0.5 Haemophilus influenzae (ATCC 49247) 0.5 － ? Haemophilus influenzae (ESBL) <0.03 － 0.12 Haemophilus influenzae (ESBL) ≤0.03 － 0.5 Haemophilus influenzae (ESBL) <0.03 － 0.5 Haemophilus influenzae (ESBL) ≤0.03 － 0.5 Haemophilus influenzae (NCTC 11931) 0.12 － ? Haemophilus influenzae (non-ESBL) ≤0.03 － 0.5 Haemophilus influenzae (non-ESBL) ≤0.03 － 0.5 Haemophilus parainfluenzae 0.06 － 0.13 Haemophilus spp. 0.06 － 0.5 Hafnia alvei 16 － ? Helicobacter pylori 0.5 － 4 Klebsiella oxytoca (ceftazidime-resistant) 2 － ? Klebsiella oxytoca (ceftazidime-susceptible) 0.06 － 2 Klebsiella pneumonia 0.063 － 32 Klebsiella pneumonia (ATCC 13883) ≤0.12 － ? Klebsiella pneumonia (ATCC 700603) 8 － ? Klebsiella pneumonia (OC4074) 128 － ? Klebsiella pneumonia (OC4076) 32 － ? Klebsiella pneumonia (OC4105) 32 － ? Klebsiella pneumonia (OC4110) >128 － ? Klebsiella pneumonia (OC4239) 64 － ? Klebsiella pneumonia (OC4244) >128 － ? Klebsiella pneumonia (OC4250) >128 － ? Klebsiella pneumonia (OC5064) >128 － ? Klebsiella pneumoniae (ceftazidime-resistant) 8 － 64 Klebsiella pneumoniae (ceftazidime-susceptible) 0.03 － 4 Klebsiella rhinoscleromatis >16 － ? Listeria innocua 2 － >64 Listeria ivanovii 2 － >64 Listeria monocytogenes 2 － >64 Listeria seeligeri 2 － >64 Listeria welshimeri 2 － >64 Moraxella catarrhalis 0.06 － 0.5 Moraxella catarrhalis 0.06 － 2 Moraxella catarrhalis 0.06 － 2 Moraxella catarrhalis 0.06 － 4 Moraxella catarrhalis 0.063 － 2 Moraxella catarrhalis ? － ? Moraxella catarrhalis ≤0.03 － >4 Morganella morganii 0.13 － 64 Morganella morganii 0.125 － 64 Morganella morganii 8 － >16 Neisseria gonorrhoeae (penicillin-resistant) 0.004 － 0.06 Neisseria gonorrhoeae (penicillin-susceptible) 0.004 － 0.06 Neisseria spp. 0.002 － 0.06 Pneumococci 0.03 － 4 Proteus mirabilis 0.06 － 0.13 Proteus mirabilis 0.032 － 0.125 Proteus mirabilis <=0.25 － 4 Proteus mirabilis (3750 + β­lactamase positive) 8 － ? Proteus penneri 16 － ? Proteus penneri (1767 + β­lactamase positive) 32 － ? Proteus vulgaris 0.06 － 0.5 Proteus vulgaris 0.032 － 16 Proteus vulgaris <=0.25 － >16 Proteus vulgaris (1405 + β­lactamase positive) 128 － ? Proteus vulgaris (1699 + β­lactamase positive) 128 － ? Proteus vulgaris (1765 + β­lactamase positive) >128 － ? Proteus vulgaris (1781 + β­lactamase positive) 1 － ? Providencia rettgeri ≤0.004 － 8 Providencia rettgeri ≤0.004 － 8 Providencia rettgeri 0.008 － 2 Providencia rettgeri <=0.25 － 0.5 Microorganism Genus, Species, and Strain (if shown) Concentration Range (μg/ml)Susceptibility and Providencia stuartii 0.06 Minimum－ 0.5 Inhibitory Providencia stuartii <=0.25 － >16 Pseudomonas aeruginosa >128 － ? Pseudomonas aeruginosa (ATCC 27853) >128 － ? Pseudomonas aeruginosa (carbenicillin-resistant) >64 － ? Pseudomonas aeruginosa (carbenicillin-susceptible) >64 － ? Pseudomonas aeruginosa (NCTC 10662) 128 － ? Pseudomonas cepacia 4 － >64 Pseudomonas fluorescens 8 － >64 Pseudomonas putida 8 － >64 Pseudomonas spp. 0.25 － 128 Pseudomonas stutzeri 8 － >64 Salmonella Agona 0.13 － 0.5 Salmonella Brandenburg 0.13 － 0.5 Salmonella Enteritidis 0.13 － 0.5 Salmonella typhimurium 0.13 － 0.5 Serratia fonticola >16 － ? Serratia liquefaciens 0.25 － >64 Serratia marcescens 0.5 － >128 Serratia marcescens 0.25 － >64 Serratia marcescens 2 － >16 Serratia marcescens (167 + β­lactamase positive) >128 － ? Serratia marcescens (91 + β­lactamase positive) >128 － ? Serratia plymuthica 8 － ? Serratia rubidaea (3134 + β­lactamase positive) 2 － ? Serratia rubidaea (3139 + β­lactamase positive) 4 － ? Shigella boydii 0.25 － 0.5 Shigella flexneri 0.25 － 0.5 Shigella sonnei 0.25 － 0.5 Staphylococci 1 － 128 Staphylococcus aureus (ATCC 25923) 4 － ? Staphylococcus aureus (ATCC 29213) 2 － ? Staphylococcus aureus (ATCC 6571) 1 － ? Staphylococcus aureus (methicillin-resistant) 16 － >64 Staphylococcus aureus (methicillin-resistant) 1 － >128 Staphylococcus aureus (oxacillin-susceptible) ? － ? Staphylococcus epidermidis (methicillin-resistant) 4 － >64 Staphylococcus epidermidis (methicillin-resistant) 4 － >128 Staphylococcus epidermidis (methicillin-susceptible) 0.25 － 16 Staphylococcus epidermidis (methicillin-susceptible) 0.5 － 4 Staphylococcus haemolyticus (methicillin-resistant) >64 － ? Staphylococcus hominis 0.5 － 2 Staphylococcus intermedius ? － ? Staphylococcus pseudintermedius 0.25 － 8 Staphylococcus simulans 0.5 － 2 Staphylococcus warneri 0.5 － 1 Stenotrophomonas maltophilia >128 － ? Streptococci ? － ? Streptococci (hemolytic + group A) 0.008 － 0.5 Streptococci (hemolytic + group B) 0.03 － 0.25 Streptococci (hemolytic + group C) 0.015 － 0.03 Streptococci (hemolytic + group G) 0.015 － 0.06 Streptococcus agalactiae 0.032 － 0.063 Streptococcus milleri (group) 0.015 － 0.25 Streptococcus mitior 0.015 － 0.13 Streptococcus pneumonia ? － ? Streptococcus pneumonia (ATCC 49619) 0.12 － ? Streptococcus pneumonia (ATCC 5303 parent) 0.015 － ? Streptococcus pneumonia (ATCC 6303 parent) 0.03 － ? Streptococcus pneumonia (pbp2x and pbp2b or pbp1a and pbp2x genes abnormal + penicillin) 0.125 － 8 Streptococcus pneumonia (pbp2x gene abnormal + penicillin-intermidiate) 0.063 － 2 Streptococcus pneumonia (pbpla, pbp2x, and pbp2b genes abnormal + penicillin-resistant) 1 － 32 Streptococcus pneumonia (penicillin-intermediate) 0.05 － 2 Streptococcus pneumonia (penicillin-intermediate) ≤0.03 － >4 Streptococcus pneumonia (penicillin-intermediate) <0.03 － >4 Streptococcus pneumonia (penicillin-intermediate) ≤0.03 － >4 Streptococcus pneumonia (penicillin-intermediate) ? － ? Streptococcus pneumonia (penicillin-intermediate) 0.12 － 4 Streptococcus pneumonia (penicillin-resistant) 0.063 － 16 Streptococcus pneumonia (penicillin-resistant) 1.861 － 8 Streptococcus pneumonia (penicillin-resistant) ≤0.03 － >4 Streptococcus pneumonia (penicillin-resistant) <0.03 － >4 Microorganism Genus, Species, and Strain (if shown) Concentration Range (μg/ml)Susceptibility and Streptococcus pneumonia (penicillin-resistant) ≤0.03 Minimum－ >4 Inhibitory Streptococcus pneumonia (penicillin-susceptible) ? － ? Streptococcus pneumonia (penicillin-susceptible) ≤0.03 － 4 Streptococcus pneumonia (penicillin-susceptible) <0.03 － 4 Streptococcus pneumonia (penicillin-susceptible) ≤0.03 － 4 Streptococcus pneumonia (penicillin-susceptible) 0.016 － 0.5 Streptococcus pneumonia (penicillin-susceptible) 0.023 － 0.064 Streptococcus pneumonia (penicillin-susceptible) 0.008 － 1 Streptococcus pneumonia (penicillin-susceptible) 0.008 － 2 Streptococcus pneumoniae (penicillin-susceptible) 0.015 － 0.13 Streptococcus pyogenes ≤0.004 － 2 Xanthomonas maltophilia >64 － ? Yersinia enterocolitica 0.5 － 2 The data above is sourced from The Antimicrobial Index. For further assistance, please contact us at [email protected] or visit www.toku-e.com..
Load more

Recommended publications
  • Downloads/Bin/Fastq Quality Filter -Q20 -P90 -Q33
    Biological Reduction of Selenium Oxyanions in the Presence of Nitrate anions using Anaerobic Microbes by Gaurav Subedi B.Sc., Jacobs University Bremen, 2010 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Chemical and Biological Engineering) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) July 2016 © Gaurav Subedi, 2016 Abstract Biological selenium reduction has emerged as a viable solution for the removal of toxic selenium from the environment. However, the presence of nitrate hinders selenium reduction by acting as a competitive electron acceptor. The present thesis investigated the use of local mine-impacted sediment as an inoculum for selenium reduction and studied the affect of nitrate on the removal of selenium. Sediment samples, impacted by mining activities, were collected from two vastly different sites of the Elk River Valley. These sediments namely; Goddard Marsh and Mature Tailing Coal, were enriched for selenium reducing bacterial consortium under high selenium and varying nitrate concentrations to put additional selection pressure. Ultimately, two cultures from Goddard Marsh enriched under low and high nitrate condition as well as one culture from Mature Tailing Coal enriched under moderate nitrate condition were used to access the affect of nitrate on selenium reduction using central composite design matrix. The extent of Se reduction was highest in the Goddard Marsh enrichment with no nitrate while enrichment with moderate and high nitrate reduced selenium poorly. ANOVA results from the CCD experiment in Goddard Marsh enrichment with no nitrate indicated no affect of nitrate in Se reduction. Two primer sets targeting the selenate redutase (serA) from Thauera selenatis and nitrite reductase (nirK) from denitrifying population were used to quantify the population of selenium reducing and denitrifying population in the CCD experiment.
    [Show full text]
  • Pdfs/ Ommended That Initial Cultures Focus on Common Pathogens, Pscmanual/9Pscssicurrent.Pdf)
    Clinical Infectious Diseases IDSA GUIDELINE A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya J. Michael Miller,1 Matthew J. Binnicker,2 Sheldon Campbell,3 Karen C. Carroll,4 Kimberle C. Chapin,5 Peter H. Gilligan,6 Mark D. Gonzalez,7 Robert C. Jerris,7 Sue C. Kehl,8 Robin Patel,2 Bobbi S. Pritt,2 Sandra S. Richter,9 Barbara Robinson-Dunn,10 Joseph D. Schwartzman,11 James W. Snyder,12 Sam Telford III,13 Elitza S. Theel,2 Richard B. Thomson Jr,14 Melvin P. Weinstein,15 and Joseph D. Yao2 1Microbiology Technical Services, LLC, Dunwoody, Georgia; 2Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 3Yale University School of Medicine, New Haven, Connecticut; 4Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland; 5Department of Pathology, Rhode Island Hospital, Providence; 6Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill; 7Department of Pathology, Children’s Healthcare of Atlanta, Georgia; 8Medical College of Wisconsin, Milwaukee; 9Department of Laboratory Medicine, Cleveland Clinic, Ohio; 10Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, Michigan; 11Dartmouth- Hitchcock Medical Center, Lebanon, New Hampshire; 12Department of Pathology and Laboratory Medicine, University of Louisville, Kentucky; 13Department of Infectious Disease and Global Health, Tufts University, North Grafton, Massachusetts; 14Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, Illinois; and 15Departments of Medicine and Pathology & Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey Contents Introduction and Executive Summary I.
    [Show full text]
  • Download/Issues/Mining/Reference Guide to Treatment Technologi Es for MIW.Pdf
    Removal of Soluble Selenium in the Presence of Nitrate from Coal Mining-Influenced Water by Frank Nkansah - Boadu BSc., Kwame Nkrumah University of Science and Technology, 2003 MASc., The University of British Columbia, 2013 A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Chemical and Biological Engineering) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) December 2019 © Frank Nkansah - Boadu, 2019 The following individuals certify that they have read, and recommend to the Faculty of Graduate and Postdoctoral Studies for acceptance, the dissertation entitled: Removal of Soluble Selenium in the Presence of Nitrate from Coal Mining-Influenced Water submitted by Frank Nkansah-Boadu in partial fulfillment of the requirements for the degree of Doctor of Philosophy In Chemical and Biological Engineering Examining Committee: Susan Baldwin, Chemical and Biological Engineering Supervisor Vikramaditya Yadav, Chemical and Biological Engineering Supervisory Committee Member Troy Vassos, Adjunct Professor, Civil Engineering Supervisory Committee Member Anthony Lau, Chemical and Biological Engineering University Examiner Scott Dunbar, Mining Engineering University Examiner ii Abstract Biological treatment to remove dissolved selenium from mining-influenced water (MIW) is inhibited by co-contaminants, especially nitrate. It was hypothesized that selenium reducing microorganisms can be obtained from native mine bacteria at sites affected by MIW due to the selection pressure from elevated selenium concentrations at those sites. Enrichment of these microorganisms and testing of their capacity to remove dissolved selenium from actual coal MIW was the objective of this dissertation. Fifteen sediments were collected from eleven different vegetated or non-vegetated seepage collection ponds and one non-impacted natural wetland.
    [Show full text]
  • HL7 Implementation Guide for CDA Release 2: NHSN Healthcare Associated Infection (HAI) Reports, Release 2 (U.S
    CDAR2L3_IG_HAIRPT_R2_D2_2009FEB HL7 Implementation Guide for CDA Release 2: NHSN Healthcare Associated Infection (HAI) Reports, Release 2 (U.S. Realm) Draft Standard for Trial Use February 2009 © 2009 Health Level Seven, Inc. Ann Arbor, MI All rights reserved HL7 Implementation Guide for CDA R2 NHSN HAI Reports Page 1 Draft Standard for Trial Use Release 2 February 2009 © 2009 Health Level Seven, Inc. All rights reserved. Co-Editor: Marla Albitz Contractor to CDC, Lockheed Martin [email protected] Co-Editor/Co-Chair: Liora Alschuler Alschuler Associates, LLC [email protected] Co-Chair: Calvin Beebe Mayo Clinic [email protected] Co-Chair: Keith W. Boone GE Healthcare [email protected] Co-Editor/Co-Chair: Robert H. Dolin, M.D. Semantically Yours, LLC [email protected] Co-Editor Jonathan Edwards CDC [email protected] Co-Editor Pavla Frazier RN, MSN, MBA Contractor to CDC, Frazier Consulting [email protected] Co-Editor: Sundak Ganesan, M.D. SAIC Consultant to CDC/NCPHI [email protected] Co-Editor: Rick Geimer Alschuler Associates, LLC [email protected] Co-Editor: Gay Giannone M.S.N., R.N. Alschuler Associates LLC [email protected] Co-Editor Austin Kreisler Consultant to CDC/NCPHI [email protected] Primary Editor: Kate Hamilton Alschuler Associates, LLC [email protected] Primary Editor: Brett Marquard Alschuler Associates, LLC [email protected] Co-Editor: Daniel Pollock, M.D. CDC [email protected] HL7 Implementation Guide for CDA R2 NHSN HAI Reports Page 2 Draft Standard for Trial Use Release 2 February 2009 © 2009 Health Level Seven, Inc. All rights reserved. Acknowledgments This DSTU was produced and developed in conjunction with the Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), and Centers for Disease Control and Prevention (CDC).
    [Show full text]
  • Synonymy of Enterobacter Cancerogenus (Urosevik 1966) Dickey and Zumoff 1988 and Enterobacter Taylorae Farmer Et Al
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, July 1994, p. 586-587 Vol. 44, No. 3 0020-7713/94/$04.00+0 Copyright 0 1994, International Union of Microbiological Societies Taxonomic Notes: Synonymy of Enterobacter cancerogenus (UroSevik 1966) Dickey and Zumoff 1988 and Enterobacter taylorae Farmer et al. 1985 and Resolution of an Ambiguity in the Biochemical Profile H. C. SCHQ)NHEYDER,l* K. T. JENSEN,2 AND W. FREDERIKSEN3 Department of Clinical Microbiology, Aalborg Hospital, DK-9000 Aalborg, Department of Clinical Microbio!ogy, Esbjerg Hospital, DK-6700 Esbjerg, and Department of Clinical Microbiology, Statens Seruminstitut, DK-2300 Copenhagen S, Denmark The descriptions of Enterobacter taylorae and Enterobacter cancerogenus show differences in key reactions (ornithine decarboxylase and D-sorbitol fermentation) that have not received attention and are inconsistent with the synonymy proposed by Grimont and Ageron (P. A. D, Grimont and E. Ageron, Res. Microbiol. 140459-465, 1989). A reassessment of the biochemical properties confirms that they are synonymous. We believe that the priority of E. cancerogenus should be maintained in diagnostic and clinical microbiology even if the epithet could be misunderstood in a clinical setting. In 1985 the name Enterobacter taylorae was proposed by TABLE 1. Comparison of biochemical reactions of type strains for Farmer et al. (2) for isolates related to Enterobacter cloacae E. cancerogenus and E. taylorae ~ ~ ~~ that did not ferment saccharose, raffinose, adonitol, myo- E. taylorae CDC E. cancerogenus inositol, or D-sorbitol. However, in 1989 Grimont and Ageron 2126-81 (= NCPPB 2176T ATCC 35317=) from (3) reported that E. taylorae and Enterobacter cancerogenus from source": form one genomic group with one biotype.
    [Show full text]
  • WO 2015/077278 Al 28 May 2015 (28.05.2015) W P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/077278 Al 28 May 2015 (28.05.2015) W P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A 63/00 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US20 14/066296 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 19 November 2014 (19.1 1.2014) KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (25) Filing Language: English PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (26) Publication Language: English SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/906,676 20 November 2013 (20. 11.2013) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant: NOVOZYMES BIOAG A/S [DK/DK]; GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, Krogshoejvej 36, DK-2880 Bagsvaerd (DK).
    [Show full text]
  • Diversity of the Human Gastrointestinal Microbiota Novel Perspectives from High Throughput Analyses
    Diversity of the Human Gastrointestinal Microbiota Novel Perspectives from High Throughput Analyses Mirjana Rajilić-Stojanović Promotor Prof. Dr W. M. de Vos Hoogleraar Microbiologie Wageningen Universiteit Samenstelling Promotiecommissie Prof. Dr T. Abee Wageningen Universiteit Dr J. Doré INRA, France Prof. Dr G. R. Gibson University of Reading, UK Prof. Dr S. Salminen University of Turku, Finland Dr K. Venema TNO Quality for life, Zeist Dit onderzoek is uitgevoerd binnen de onderzoekschool VLAG. Diversity of the Human Gastrointestinal Microbiota Novel Perspectives from High Throughput Analyses Mirjana Rajilić-Stojanović Proefschrift Ter verkrijging van de graad van doctor op gezag van de rector magnificus van Wageningen Universiteit, Prof. dr. M. J. Kropff, in het openbaar te verdedigen op maandag 11 juni 2007 des namiddags te vier uur in de Aula Mirjana Rajilić-Stojanović, Diversity of the Human Gastrointestinal Microbiota – Novel Perspectives from High Throughput Analyses (2007) PhD Thesis, Wageningen University and Research Centre, Wageningen, The Netherlands – with Summary in Dutch – 214 p. ISBN: 978-90-8504-663-9 Abstract The human gastrointestinal tract is densely populated by hundreds of microbial (primarily bacterial, but also archaeal and fungal) species that are collectively named the microbiota. This microbiota performs various functions and contributes significantly to the digestion and the health of the host. It has previously been noted that the diversity of the gastrointestinal microbiota is disturbed in relation to several intestinal and not intestine related diseases. However, accurate and detailed defining of such disturbances is hampered by the fact that the diversity of this ecosystem is still not fully described, primarily because of its extreme complexity, and high inter-individual variability.
    [Show full text]
  • YÖK Tez No: 479704
    EGE ÜNİVE RSİTESİ DOKTORA TEZİ Ü Ü S S Ü Ü T T İ İ BALÇOVA YÜZEYSEL TERMAL SU T T S S KAYNAKLARINDAN ARSENİK METABOLİZE N N E E EDEN BAKTERİLERİN İZOLASYONU VE İ İ İDENTİFİKASYONU R R E E L L M M Ece SÖKMEN YILMAZ İ İ L L Tez Danışmanı: Prof. Dr. İsmail KARABOZ İ İ B B Biyoloji Anabilim Dalı N N E E Sunuş Tarihi: 17 .05.2017 F F . Ü Ü . E E Bornova-İZMİR 2017 EGE ÜNİVERSİTESİ FEN BİLİMLERİ ENSTİTÜSÜ (DOKTORA TEZİ) BALÇOVA YÜZEYSEL TERMAL SU KAYNAKLARINDAN ARSENİK METABOLİZE EDEN BAKTERİLERİN İZOLASYONU VE İDENTİFİKASYONU Ece SÖKMEN YILMAZ Tez Danışmanı: Prof. Dr. İsmail KARABOZ Biyoloji Anabilim Dalı Sunuş Tarihi: 17.05.2017 Bornova-İZMİR 2017 vii ÖZET BALÇOVA YÜZEYSEL TERMAL SU KAYNAKLARINDAN ARSENİK METABOLİZE EDEN BAKTERİLERİN İZOLASYONU VE İDENTİFİKASYONU SÖKMEN YILMAZ, Ece Doktora Tezi, Biyoloji Anabilim Dalı Tez Danışmanı: Prof. Dr. İsmail KARABOZ Mayıs 2017, 96 sayfa Bakteriyel arsenik metabolizması son yıllarda ilgi çeken konulardandır. Ağır metaller termal sularda boldur. İzmir Balçova’daki termal sularının karıştığı yüzey sularından izole edilen arsenik dirençli bakteriler üzerine bilenenler yok denecek kadar azdır. Bu çalışmanın amacı bu bakterileri tanımlamak ve literatürdeki arsenik metabolizma deneylerini uygulayarak ileriye yönelik veri elde edilmesini sağlamaktır. Bu çalışmada 500 mM arsenat içeren PCA’da üreyebilen on iki izolat tanımlanmıştır. Api 50 CH ve Api 20 E ile fenotipik karekterizasyonları belirlenen izolatların kısmi 16S rDNA dizi benzerliklerine göre birer tanesi Rhodococcus sp., Pannonibacter phragmitetus, Micrococcus sp., Enterobacter sp., Microbacterium sp. iken yedisi Pseudomonas sp.’dir. LB sıvı besiyerleri kullanılarak yüksek değerde arsenik MİK’leri saptandı.
    [Show full text]
  • Screening Hydrolase-Producing Environmental Bacteria Towards Their Application in Bioremediation Microbiology
    Screening hydrolase-producing environmental bacteria towards their application in bioremediation Maria Cristina Lopes Matias Thesis to obtain the Master of Science Degree in Microbiology Supervisor: Professor Rogério Paulo de Andrade Tenreiro Co-supervisor: Professor Nuno Gonçalo Pereira Mira Examination Committee Chairperson: Professor Isabel Maria de Sá Correia Leite de Almeida Supervisor: Professor Rogério Paulo de Andrade Tenreiro Member of the Committee: Professor Ana Cristina Anjinho Madeira Viegas October 2019 Declaration I declare that this document is an original work of my own authorship and that it fulfills all the requirements of the Code of Conduct and Good Practices of the Universidade de Lisboa. i Preface The work presented in this thesis was performed at Lab Bugworkers | M&B-BioISI, Faculty of Sciences of the University of Lisbon (Lisbon, Portugal), during the period from September 2017 to October 2019, under the supervision of Professor Rogério Tenreiro. The thesis was co-supervised at Instituto Superior Técnico (Lisbon, Portugal) by Professor Nuno Mira. ii Acknowledgments This thesis is the end result of the work developed within the Microbiology & Biotechnology Group of Biosystems and Integrative Sciences Institute (M&B-BioISI), at Lab Bugworkers | M&B-BioISI, located in the Innovation Centre from the Faculty of Sciences of the University of Lisbon, Tec Labs. It would not have been successfully achieved without the help and collaboration of several people, to whom I would like to express my sincere gratitude. First, and foremost, I would like to thank my supervisor, Professor Rogério Tenreiro, for challenging me with this project. I have to thank him for the patience for my endless questions, for letting me error along the way (and learn with those errors), and for all the ideas to improve my work.
    [Show full text]
  • Agriculture/Food Industry
    Agriculture/Food Industry The agriculture and food industries saw their beginnings more than 10,000 years ago and have easily become the world’s largest industries, according to World Wildlife Fund. They employ more than one billion people and generate over $1.3 trillion dollars worth of food annually. Along with food cultivation comes food safety and control of foodborne disease outbreaks. In 2014, the Centers for Disease Control and Prevention (CDC) monitored between 20 and 40 potential food poisoning or related clusters each week and investigated more than 220 multistate clusters. From E. coli to salmonella, it is widely known that these types of bacteria have the ability to spread quickly. This year, the National Inventors Hall of Fame will induct two inventors who enhanced our understanding of microbiology and bacteriology and continue to influence bacteriologists and microbiologists today. In addition, the National Inventors Hall of Fame will honor a pioneering woman inventor in the area of water control and irrigation. As the United States Department of Agriculture works towards shining a light on women in agriculture through their #womeninag campaign, the National Inventors Hall of Fame will in tandem honor the past and influence the future of women in agriculture. John H. Silliker & Welton I. Taylor Harriet W. R. Strong While working at Swift & Company, John Silliker met Welton Taylor. Swift, Harriet Strong received a a food processing company, had experienced a salmonella outbreak in patent in 1887 for her invention a dried egg yolk product meant for babies. Together, Silliker and Taylor of a system of dams and developed a highly accurate method to test egg yolks for salmonella, reservoirs for water storage a method that is still used today in labs around the world.
    [Show full text]
  • A Review of the Taxonomy, Genetics and Biology of the Genus Escherichia and the Type Species Escherichia Coli
    Canadian Journal of Microbiology A Review of the Taxonomy, Genetics and Biology of the Genus Escherichia and the Type Species Escherichia coli Journal: Canadian Journal of Microbiology Manuscript ID cjm-2020-0508.R1 Manuscript Type: Review Date Submitted by the 13-Feb-2021 Author: Complete List of Authors: Yu, Daniel ; University of Alberta School of Public Health, Room 357 South Academic Bldg, University of Alberta Banting, Graham; University of Alberta School of Public Health, Room 357 South Academic Bldg, University of Alberta Neumann, DraftNorman; University of Alberta School of Public Health, Room 357 South Academic Bldg, University of Alberta; Keyword: Escherichia coli, taxonomy, host specificity, ecotype, genetics Is the invited manuscript for consideration in a Special Not applicable (regular submission) Issue? : © The Author(s) or their Institution(s) Page 1 of 67 Canadian Journal of Microbiology A Review of the Taxonomy, Genetics and Biology of the Genus Escherichia and the Type Species Escherichia coli Daniel Yu1, Graham Banting1, and Norman F. Neumann1* 1School of Public Health, University of Alberta, Edmonton, Alberta, Canada, T6G IC9 Draft * Corresponding Author: Dr. Norman F. Neumann Professor and Vice Dean School of Public Health Room 3-381 Edmonton Clinic Health Academy University of Alberta Edmonton, Alberta, Canada. T6G 1C9 Email: [email protected] 1 © The Author(s) or their Institution(s) Canadian Journal of Microbiology Page 2 of 67 ABSTRACT Historically, bacteriologists have relied heavily on biochemical and structural phenotypes for bacterial taxonomic classification. However, advances in comparative genomics has led to greater insights into the remarkable genetic diversity within the microbial world, and even within well-accepted species such as Escherichia coli.
    [Show full text]
  • Phylogenetic Diversity of Fast-Growing Bacteria Isolated From
    Advanced Studies in Biology, Vol. 1, 2009, no. 7, 333 - 344 Phylogenetic Diversity of Fast-Growing Bacteria Isolated from Superficial Water of Lake Martel, a Saline Subterranean Lake in Mallorca Island (Spain) Formed by Filtration from the Mediterranean Sea through Underground Rocks Raúl Rivas, Paula García-Fraile, Pedro F. Mateos Eustoquio Martinez-Molina and Encarna Velázquez* Departamento de Microbiología y Genética Universidad de Salamanca. Salamanca, Spain *Corresponding author: Encarna Velázquez, Departamento de Microbiología y Genética. Lab. 209. Edificio Departamental de Biología. Campus Miguel de Unamuno. 37007 Salamanca. Spain e-mail: [email protected] Abstract The bacterial diversity of lake Martel (Mallorca Island, Spain), the longest known subterranean lake, has been few studied despite the interest of this aquatic ecosystem that maintains a constant temperature near to 18°C and has low salt content. In this work fifteen strains isolated in presence of low salt concentration were grouped on basis of their Two Primers (TP)-RAPD patterns and classified into different genera and species on basis of their 16S rRNA gene sequences. The isolates were closely related to Alcanivorax dieselolei, Cobetia marina, Chromohalobacter israelensis, Thalassospira lucentensis, Pseudomonas pseudoalcaligenes, Pseudoalteromonas sp., Stenotrophomonas maltophilia, Enterobacter cancerogenous, Micrococcus luteus and Bacillus pumilus. The results obtained showed the complexity of bacterial populations 334 Raúl Rivas et al living in Martel ecosystem because the strains isolated belong to very divergent phylogenetic groups mostly within Proteobacteria and are related to bacterial species found in water related sources. Keywords: water/Lake Martel/bacteria/phylogeny/diversity Introduction The Lake Martel located inside the Drac Coves (Mallorca Island, Spain) was discovered by E.
    [Show full text]